News
Novo Nordisk Files Lawsuit Against Lilly Over ‘Misleading’ GLP-1 Ads
Novo Nordisk alleges Lilly’s advertisements for Zepbound and Mounjaro mislead consumers by comparing the drugs with lower-dose versions of Wegovy and Ozempic.

